TuesdayAug 19, 2025 12:55 pm

QualityStocksNewsBreaks – Branded Legacy, Inc. (OTC: BLEG) Subsidiary Forms Strategic Partnership With McMaster University

Branded Legacy (OTC: BLEG), a diversified holdings company focused on health and wellness solutions, announced that its wholly owned subsidiary, Bio-Legacy Evaluative Group, has partnered with McMaster University to evaluate innovative products for populations affected by addictions. The collaboration will combine McMaster’s expertise in addiction medicine, clinical trials, and guideline development with Bio-Legacy’s real-world scientific experience to advance rigorous evaluations, clinical trials, and regulatory submissions, supporting the development of accessible, cost-effective interventions aimed at reducing overdose deaths, minimizing drug-related harms, and promoting long-term recovery. To view the full press release, visit https://ibn.fm/qF5UU About Branded Legacy, Inc. Branded Legacy, Inc. (OTC: BLEG) is…

Continue Reading

TuesdayAug 12, 2025 9:35 am

QualityStocksNewsBreaks – InvestorNewsBreaks – Branded Legacy, Inc. (OTC: BLEG) Completes Acquisition of Bio Legacy Evaluative Group, Expanding into Biotech and Medical Devices

Branded Legacy (OTC: BLEG), a diversified holdings company in the health and wellness sector, has completed its acquisition of Bio Legacy Evaluative Group, formerly Menlo Health, in an all-stock deal valued at $1.5 million in Preferred D shares. The transaction, closed July 31, 2025, positions Branded Legacy to address global health challenges such as the addiction epidemic and vaccine distribution inefficiencies. Under CEO Amin Janmohamed, Bio Legacy brings a patented all-in-one intranasal naloxone device targeting a market projected to grow from $371 million in 2022 to over $1.16 billion by 2032, along with technology for nasal delivery of vaccines and cold-chain…

Continue Reading

MondayJul 14, 2025 2:10 pm

QualityStocksNewsBreaks – Announces Leadership Overhaul and Strategic Merger in Addiction Therapeutics

Branded Legacy (OTC: BLEG), a diversified holdings firm, announced a full leadership transition and a pending merger aimed at entering the addiction therapeutics space. Interim CEO Jeffery Robison now leads the company following the resignation of the entire prior management team. A Letter of Intent has been submitted for a merger with a company specializing in advanced intranasal drug delivery, including a patented all-in-one naloxone device. The combined entity projects $40 million in first-year revenue and aims to disrupt the opioid overdose and broader addiction treatment markets with scalable, cost-effective solutions. Merger closing is expected within two weeks, pending approvals. To…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered